Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 278-188-0 | CAS number: 75314-26-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 26 April - 20 June, 2017
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 017
- Report date:
- 2017
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Version / remarks:
- 21st July, 1997
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
- Version / remarks:
- 30 May, 2008
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.5100 - Bacterial Reverse Mutation Test (August 1998)
- Version / remarks:
- August 1998
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- other: – ICH Guidance S2(R1): Guidance on Genotoxicity Testing and Data Interpretation for Pharmaceuticals Intended for Human Use, 2012
- Version / remarks:
- 2012
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- Benzene, 1,1'-oxybis[methyl-, sulfonated, ammonium salts
- EC Number:
- 278-188-0
- EC Name:
- Benzene, 1,1'-oxybis[methyl-, sulfonated, ammonium salts
- Cas Number:
- 75314-26-0
- Molecular formula:
- C14H13O4S . NH4 - C70H60O19S6 . 2NH4
- IUPAC Name:
- Benzene, 1,1'-oxybis[methyl-, sulfonated, ammonium salts
- Reference substance name:
- Ammonium sulphate
- EC Number:
- 231-984-1
- EC Name:
- Ammonium sulphate
- Cas Number:
- 7783-20-2
- Molecular formula:
- H8N2O4S
- IUPAC Name:
- Ammonium tetraoxosulfate (VI)
- Reference substance name:
- Water
- EC Number:
- 231-791-2
- EC Name:
- Water
- Cas Number:
- 7732-18-5
- Molecular formula:
- H2O
- IUPAC Name:
- Oxidane
- Test material form:
- liquid: viscous
- Details on test material:
- ca 50% aquaous viscous solution
Batch No: INB3209089
Storage: At room temperature, protected from light
Expiring date: 2018-04-30
Constituent 1
Constituent 2
Constituent 3
- Specific details on test material used for the study:
- Expiring date: 10 January 2018
Method
- Target gene:
- In addition to histidine and tryptophan mutation, each strain has additional mutations which enhance its sensitivity to mutagens. The uvrB (uvrA) strains are defective in excision repair. It causes the strains to be more sensitive to the mutagenic and lethal effects of a wide variety of mutagens because they cannot repair DNA damages. rfa mutation increases the permeability of the bacterial lipopolysaccharide wall for larger molecules. The plasmid pKM101 (TA98, TA100) carries the muc+ gene which participates in the error-prone "SOS" DNA repair pathway induced by DNA damage. This plasmid also carries an ampicillin resistance transfer factor (R-factor) which is used to identify its presence in the cell. The Escherichia coli strain used in this test (WP2uvrA) is also defective in DNA excision repair.
Species / strain
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and E. coli WP2
- Metabolic activation:
- with and without
- Metabolic activation system:
- metabolic activation S9 Mix; which is a cofactor-supplemented post-mitochondrial fraction (S9)
- Test concentrations with justification for top dose:
- The Benzene, 1,1’oxybis(methyl-, sulfonated, ammonium salt (ca 50 %) concentrations investigated in the Initial and Confirmatory Mutation Tests:
5000, 1600, 500, 160, 50 and 16 µg/plate. - Vehicle / solvent:
- In the preliminary Range Finding Test ultrapure water (ASTM Type 1) was found as appropriate vehicle for preparing the test item solutions. This vehicle is compatible with the survival of the bacteria and the S9 activity.
At the preparation of the test item stock solution a correction (multiplier) factor of 1.96 (1/0.511=1.96) based on the active component content was taken into consideration.
Controls
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- Positive controls:
- yes
- Positive control substance:
- 9-aminoacridine
- sodium azide
- methylmethanesulfonate
- other: 4-Nitro-1,2-phenylenediamine, 2-aminoanthracene, Dimethyl sulfoxide
- Details on test system and experimental conditions:
- The tester strains arrived to the test facility in a form of disc cultures. The origin of the following tester strains: Salmonella typhimurium TA98, TA100, TA1535, TA1537 and Escherichia coli WP2 uvrA:
Supplier: Trinova Biochem GmbH; Rathenau Str. 2; D-35394 Giessen, Germany;
Storage of Tester Strains
The strains are stored at -80 ± 10ºC in the Laboratory of TOXI-COOP ZRT. in the form of lyophilized discs and in frozen permanent copies. Frozen permanent cultures of the tester strains are prepared from fresh, overnight cultures to which DMSO (8 % (v/v)) is added as a cryoprotective agent.
Manufacturer: MOLTOX INC., P.O. BOX 1189; BOONE, NC 28607 USA.
Frozen stock cultures were prepared from the disc cultures.
Storage of Tester Strains
The strains are stored at -80 ± 10ºC in the Laboratory of TOXI-COOP ZRT. in the form of lyophilized discs and in frozen permanent copies. Frozen permanent cultures of the tester strains are prepared from fresh, overnight cultures to which DMSO (8 % (v/v)) is added as a cryoprotective agent.
Confirmation of Phenotypes of Tester Strains
The phenotypes of the tester strains used in the bacterial reverse mutation assays with regard to membrane permeability (rfa), UV sensitivity (uvrA and uvrB), ampicillin resistance (amp), as well as spontaneous mutation frequencies are checked regularly according to Ames et al.
Established procedures (Standard Operating Procedures) for the preparations of each batch of frozen stock culture and raw data and reports of phenotype confirmation are stored in the Laboratory of TOXI-COOP ZRT.
spontaneous Reversion of Tester Strains
Each tester strain reverts spontaneously at a frequency that is characteristic for the strain. Spontaneous reversions of the test strains to histidine or tryptophan prototrophs are measured routinely in mutagenicity experiments and expressed as the number of spontaneous revertants per plate.
Procedure for Bacterial Cultures
The frozen bacterial cultures were thawed at room temperature and 200 µL inoculum was used to inoculate each 50 mL of Nutrient Broth No. 2 for the overnight cultures in the assay. The cultures were incubated for approximately 11-13 hours in a 37oC Benchtop Incubator Shaker.
Viability and the Cell Count of the Testing Bacterial Cultures
The viability of each testing culture was determined by plating 0.1 mL of the 10-5, 10-6, 10-7 and 10-8 dilutions of cultures on nutrient agar plates. The viable cell number of the cultures was determined by manual colony counting.
Media
The Minimal Glucose Agar (MGA) Plates
Ready-to-use minimal glucose agar (MGA) plates were used in the study. The origin of the ready-to use MGA plates:
Supplier: VWR International;
Manufacturer: Merck Life Science GmbH, Germany.
Certificates of Analysis* were obtained from the supplier.
Typical composition (g/1000 mL) of MGA plates:
Glucose 20.0 g
Magnesium sulfate 0.2 g
Citric acid 2.0 g
di-Potassium hydrogenphosphate 10.0 g
Sodium ammonium hydrogenphosphate 3.5 g
Agar agar 13.0 g
* Batch No.: 142584; Expiry date: 22 May 2017; (used in the Informatory Toxicity Test)
143858; Expiry date: 16 August 2017; (used in the Initial and the Confirmatory Mutation Tests)
Nutrient Broth No. 2
Nutrient broth No. 2. 25.0 g
Ultrapure water ad 1000.0 mL
Sterilization for 20 minutes was performed at 121°C in an autoclave.
Nutrient Agar
Nutrient Agar 20.0 g
Ultrapure water ad 1000.0 mL
Sterilization for 20 minutes was performed at 121°C in an autoclave.
Top Agar for Salmonella typhimurium Strains
Agar solution:
Agar Bacteriological 4.0 g
NaCl 5.0 g
Ultrapure water ad 1000.0 mL
Sterilization for 20 minutes was performed at 121°C in an autoclave.
Histidine – Biotin solution (0.5 mM):
D-Biotin 122.2 mg
L-Histidine•HCl H2O 104.8 mg
Ultrapure water ad 1000.0 mL
Sterilization was performed by filtration through a 0.22 µm membrane filter.
Complete Top Agar for Salmonella typhimurium strains:
Histidine – Biotin solution (0.5 mM) 100.0 mL
Agar solution 900.0 mL
Top Agar for Escherichia coli Strain
Tryptophan solution (2 mg/mL):
L-Tryptophan 2000.0 mg
Ultrapure water ad 1000.0 mL
Sterilization was performed by filtration through a 0.22 µm membrane filter.
Complete Top Agar for Escherichia coli strain:
Nutrient Broth by (Section: 5.4.2) 50.0 mL
Tryptophan solution (2 mg/mL) 2.5 mL
Agar solution by (Section: 5.4.4) 947.5 mL
Metabolic Activation System
The test bacteria were also exposed to the test item in the presence of an appropriate metabolic activation system, which is a cofactor-supplemented post-mitochondrial fraction (S9).
Rat Liver S9 Fraction
The S9 fraction of Phenobarbital (PB) and ß-naphthoflavone (BNF)-induced rat liver was provided by Trinova Biochem GmbH (Rathenau Str. 2; D-35394 Giessen, Germany; Manufacturer: MOLTOX INC., P.O. BOX 1189; BOONE, NC 28607 USA).
The Quality Control & Production Certificate of each lot of S9 was obtained from the supplier1). The original Quality Control & Production Certificates of rat liver S9 are stored in the Laboratory of TOXI-COOP ZRT. The copies of the quality control certificates of the used S9 lots are given in Appendix VI. The following lots of the S9 were applied:
1) Lot Number: 3634; Expiry date: May 12, 2018; Protein content: 40.3 mg/mL
(used in the Informatory Toxicity and Confirmatory Mutation Test);
Lot Number: 3662; Expiry date: July 07, 2018; Protein content: 40.5 mg/mL
(used in the Informatory Toxicity Test);
Lot Number: 3712; Expiry date: November 03, 2018; Protein content: 34.3 mg/mL
(used in the Confirmatory Mutation Test);
Lot Number: 3727; Expiry date: December 01, 2018; Protein content: 33.7 mg/mL
(used in the Initial and Confirmatory Mutation Tests).
The S9 Mix (with Rat Liver S9)
Salt solution for S9 Mix Final concentration in S9 Mix
NADP Na 7.66 g 4 mM
D-glucose-6 phosphate Na 3.53 g 5 mM
MgCl2 1.90 g 8 mM
KCl 6.15 g 33 mM
Ultrapure water ad 1000 mL
Sterilized by filtration through a 0.22 µm membrane filter.
The complete S9 Mix was freshly prepared containing components as follows:
Ice cold 0.2 M sodium phosphate-buffer, pH 7.4 500 mL
Rat liver homogenate (S9) 100 mL
Salt solution for S9 Mix 400 mL
The S9 Mix was kept in an ice bath before it was added to the culture medium.
Sodium Phosphate Buffer (0.2 M, pH 7.4)
Solution A:
Na2HPO4 x 12H2O 71.63 g
Ultrapure water ad 1000 mL
Solution B:
NaH2PO4 x H2O 27.6 g
Ultrapure water ad 1000 mL
Solution A 880 mL
Solution B 120 mL*
* The components were mixed in the above ratio; thereafter the pH was checked and corrected. The correction was performed with admixture of the solution A or B.
After the pH setting the sterilization was performed by filtration through a 0.22 µm membrane filter. - Rationale for test conditions:
- Based on the results of the Solubility and the Concentration Range Finding Tests the test item was dissolved in ultrapure water (ASTM Type I). The vehicle was compatible with the survival of the bacteria and the S9 activity and appropriate historical control database is available in the testing laboratory.
Based on the results of the preliminary Concentration Range Finding Test the following concentrations of the test item were prepared and investigated in the Initial and Confirmatory Mutation Tests: 5000; 1600; 500; 160; 50 and 16 µg/plate.
At the preparation of the test item stock solution a correction (multiplier) factor of 1.96 (1/0.511=1.96) based on the active component content (of 51.1 %) was taken into consideration.
No precipitation of the test item was observed on the plates in the examined bacterial strains at any examined concentration level (±S9 Mix) throughout the study.
The revertant colony numbers of vehicle control (ultrapure water (ASTM Type I)) plates with and without S9 Mix demonstrated the characteristic mean number of spontaneous revertants that was in line with the corresponding historical control data ranges.
The reference mutagen treatments (positive controls) showed the expected, biological relevant increases (more than 3-fold increase) in induced revertant colonies and nearly all the number of revertants fell in the corresponding historical control ranges, thereby meeting the criteria for the positive control in all experimental phases, in all tester strains. - Evaluation criteria:
- The colony numbers on the untreated, vehicle control, positive control and the test item treated plates were determined visually by manual counting, and the mean values, standard deviations and the mutation rates were calculated.
A test item is considered mutagenic if:
- a dose–related increase in the number of revertants occurs and/or;
- a reproducible biologically relevant positive response for at least one of the dose groups occurs in at least one strain with or without metabolic activation.
An increase is considered biologically relevant if:
- in strain Salmonella typhimurium TA100 the number of reversions is at least twice as high as the reversion rate of the vehicle control,
- in strain Salmonella typhimurium TA98, TA1535, TA1537 and Escherichia coli WP2 uvrA the number of reversions is at least three times higher than the reversion rate of the vehicle control.
According to the guidelines, the biological relevance of the results is the criterion for the interpretation of results, a statistical evaluation of the results is not regarded as necessary.
Criteria for a Negative Response:
A test item is considered non-mutagenic if it produces neither a dose-related increase in the number of revertants nor a reproducible biologically relevant positive response at any of the dose groups, with or without metabolic activation. - Statistics:
- The mean values and appropriate standard deviations and mutation rates were calculated by EXCEL software.
Results and discussion
Test resultsopen allclose all
- Key result
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- Validity of the Performed Experiments
The tester strains used in this study demonstrated the specific phenotype characteristics, were in line with the corresponding historical control data ranges , and showed the adequate strain culture titer .
Each batch of the S9 fraction used in this test had the appropriate biological activity and was active in the applied system .
Each of the investigated reference mutagens showed the expected increase (at least a
3-fold increase) in induced revertant colonies over the mean value of the respective vehicle control in both main experimental phases and the number of revertants in most cases fell in the corresponding historical control ranges , thereby meeting the criteria for the positive control in the main experimental phases, in all tester strains .
The spontaneous revertant colony numbers of the ultrapure water (ASTM Type 1) vehicle control plates showed characteristic mean numbers agreed with the actual historical control data ranges in all strains in both main experimental phases.
Seven concentration levels were investigated in the Informatory Toxicity Test and six in the main mutation experiments (Initial and Confirmatory Mutation Tests.
In the performed experimental phases there were at least five analyzable concentrations and a minimum of three non-toxic and non-precipitated dose levels at each tester strain.
All criteria for the validity of the performed experiments have therefore been met.
Controls
In the performed Initial and Confirmatory Mutation Test multiple test items were tested with reference values from the common parallel controls.
In the Initial and Confirmatory Mutation Tests the revertant colony numbers of the ultrapure water (ASTM Type 1) vehicle control plates with and without S9 Mix were in line with the corresponding historical control data ranges.
The reference mutagen treatments (positive controls) showed the expected, biological relevant increases in induced revertant colonies in all experimental phases, in all tester strains (see in Tables of Appendices II-IV). In the Initial Mutation Test, in the case of S. typhimurium TA100 the revertant colony numbers of Sodium azide (SAZ) were above the corresponding historical control data range; however the higher counts were considered as acceptable without any effect on the final conclusion of the study .
The revertant colony numbers of the untreated and dimethyl sulfoxide (DMSO) control plates in different experimental phases were slightly higher or lower than the ultrapure water control plates. The higher or lower revertant counts of these controls remained in the corresponding historical control data ranges.
In summary, the actual values of untreated, vehicle and positive controls were in line with the criteria for validity of the assay.
Initial and Confirmatory Mutation Tests (Plate Incorporation and Pre-Incubation Tests)
No substantial increases were observed in revertant colony numbers of any of the five test strains following treatment with Benzene, 1,1’oxybis(methyl-, sulfonated, ammonium salt (ca 50 %) at any concentration level, either in the presence or absence of metabolic activation (S9 Mix) in the performed experiments.
In the performed experiments, sporadically increased revertant colony numbers were observed. These increases did not show a dose-response relationship, were of minor intensity, and all of the increases remained far below the biologically relevant thresholds for being positive. The obtained increases were therefore considered as biologically not relevant, being in the range of the biological variability of the applied test system.
The highest revertant colony number increase was observed in the Confirmatory Mutation Test (Pre-Incubation Test) in S. typhimurium TA1537 strain, at 50 µg/plate, in the absence of metabolic activation ( S9). This value however remained in the range of the corresponding vehicle historical control data and additional concentration related increase in revertant colony counts was not noticed. The mutation rate was 1.95, which was far below the genotoxicological threshold for being positive.
In the Initial and Confirmatory Mutation Tests, unequivocal inhibitory effect of the test item on bacterial growth was not observed. All of the noticed lower revertant colony numbers (when compared to the revertant colony numbers of the corresponding vehicle control) remained in the range of the biological variability of the applied test system and the background lawn development was not affected in any case.
In the Initial Mutation Test in S. typhimurium TA100, at the concentration of 5000 µg/plate (±S9 Mix) and in the Confirmatory Mutation Test in S. typhimurium TA98, at the concentration 5000 µg/plate (+S9 Mix) the obtained revertant colony numbers were below the corresponding historical control data ranges, without any biological significance.
No precipitation of the test item was observed in the Initial and Confirmatory Mutation Tests on the plates in the examined bacterial strains at any examined concentration level (±S9 Mix). - Remarks on result:
- other: Benzene, 1,1’oxybis(methyl-, sulfonated, ammonium salt (ca 50 %) has no mutagenic activity on the applied bacterium tester strain under the test conditions used in this study.
Any other information on results incl. tables
Summary Table of the Results of the Concentration Range Finding Test
Range Finding Test (Informatory Toxicity Test) |
|
||||||||
Concentrations (mg/plate) |
Salmonella typhimuriumtester strains |
||||||||
TA 98 |
TA 100 |
||||||||
-S9 |
+S9 |
-S9 |
+S9 |
||||||
Mean values of revertants per plate and |
Mean |
MR |
Mean |
MR |
Mean |
MR |
Mean |
MR |
|
Untreated Control |
21.7 |
0.82 |
25.7 |
0.95 |
103.7 |
1.10 |
121.0 |
1.24 |
|
DMSO Control |
23.3 |
1.00 |
25.3 |
1.00 |
– |
– |
93.3 |
1.00 |
|
Ultrapure Water Control |
26.3 |
1.00 |
27.0 |
1.00 |
94.0 |
1.00 |
97.7 |
1.00 |
|
5000 |
19.7 |
0.75 |
20.7 |
0.77 |
88.0 |
0.94 |
87.3 |
0.89 |
|
1600 |
23.0 |
0.87 |
21.3 |
0.79 |
97.3 |
1.04 |
103.7 |
1.06 |
|
500 |
29.3 |
1.11 |
24.7 |
0.91 |
84.3 |
0.90 |
102.3 |
1.05 |
|
160 |
25.7 |
0.97 |
26.3 |
0.98 |
93.0 |
0.99 |
113.3 |
1.16 |
|
50 |
21.0 |
0.80 |
29.7 |
1.10 |
100.7 |
1.07 |
110.3 |
1.13 |
|
16 |
18.7 |
0.71 |
25.0 |
0.93 |
103.7 |
1.10 |
106.7 |
1.09 |
|
5 |
18.7 |
0.71 |
25.7 |
0.95 |
105.0 |
1.12 |
115.3 |
1.18 |
|
NPD (4mg) |
218.7 |
9.37 |
– |
– |
– |
– |
– |
– |
|
SAZ (2mg) |
– |
– |
– |
– |
1944.0 |
20.68 |
– |
– |
|
2AA (2mg) |
– |
– |
1746.7 |
68.95 |
– |
– |
2360.0 |
25.29 |
|
MR:Mutation Rate
NPD:4-Nitro-1,2-phenylenediamine
SAZ:Sodium azide
2AA:2-aminoanthracene
Summary Table of the Results of the Initial Mutation Test
Initial Mutation Test (Plate Incorporation Test) |
||||||||||||||||||||
Concentrations (mg/plate) |
Salmonella typhimuriumtester strains |
Escherichiacoli |
||||||||||||||||||
TA 98 |
TA 100 |
TA 1535 |
TA 1537 |
WP2uvrA |
||||||||||||||||
-S9 |
+S9 |
-S9 |
+S9 |
-S9 |
+S9 |
-S9 |
+S9 |
-S9 |
+S9 |
|||||||||||
Mean values of revertants per plate Mutation rate (MR) |
Mean |
MR |
Mean |
MR |
Mean |
MR |
Mean |
MR |
Mean |
MR |
Mean |
MR |
Mean |
MR |
Mean |
MR |
Mean |
MR |
Mean |
MR |
Untreated Control |
25.3 |
1.10 |
36.3 |
1.06 |
97.0 |
1.17 |
101.3 |
0.84 |
10.7 |
0.82 |
13.7 |
1.24 |
7.7 |
1.64 |
11.3 |
1.36 |
27.0 |
0.80 |
37.3 |
1.09 |
DMSO Control |
18.7 |
1.00 |
25.3 |
1.00 |
– |
– |
105.7 |
1.00 |
– |
– |
13.7 |
1.00 |
7.0 |
1.00 |
9.7 |
1.00 |
– |
– |
33.0 |
1.00 |
Ultrapure Water Control |
23.0 |
1.00 |
34.3 |
1.00 |
82.7 |
1.00 |
120.3 |
1.00 |
13.0 |
1.00 |
11.0 |
1.00 |
4.7 |
1.00 |
8.3 |
1.00 |
33.7 |
1.00 |
34.3 |
1.00 |
5000 |
18.3 |
0.80 |
20.0 |
0.58 |
66.0 |
0.80 |
80.0 |
0.66 |
12.7 |
0.97 |
10.0 |
0.91 |
4.7 |
1.00 |
7.3 |
0.88 |
29.0 |
0.86 |
34.7 |
1.01 |
1600 |
18.3 |
0.80 |
24.3 |
0.71 |
78.7 |
0.95 |
100.3 |
0.83 |
11.0 |
0.85 |
10.7 |
0.97 |
5.0 |
1.07 |
7.0 |
0.84 |
20.7 |
0.61 |
38.7 |
1.13 |
500 |
20.3 |
0.88 |
21.0 |
0.61 |
83.3 |
1.01 |
96.3 |
0.80 |
11.0 |
0.85 |
10.0 |
0.91 |
6.7 |
1.43 |
10.7 |
1.28 |
30.3 |
0.90 |
52.3 |
1.52 |
160 |
20.7 |
0.90 |
24.7 |
0.72 |
89.7 |
1.08 |
98.3 |
0.82 |
13.3 |
1.03 |
13.7 |
1.24 |
3.7 |
0.79 |
7.0 |
0.84 |
29.3 |
0.87 |
45.3 |
1.32 |
50 |
18.7 |
0.81 |
26.3 |
0.77 |
88.7 |
1.07 |
96.7 |
0.80 |
14.3 |
1.10 |
12.0 |
1.09 |
6.3 |
1.36 |
8.0 |
0.96 |
23.7 |
0.70 |
44.0 |
1.28 |
16 |
21.7 |
0.94 |
23.7 |
0.69 |
96.7 |
1.17 |
120.0 |
1.00 |
13.0 |
1.00 |
11.0 |
1.00 |
6.3 |
1.36 |
8.7 |
1.04 |
24.7 |
0.73 |
46.0 |
1.34 |
NPD (4mg) |
271.3 |
14.54 |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
SAZ (2mg) |
– |
– |
– |
– |
2189.3 |
26.48 |
– |
– |
862.7 |
66.36 |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
9AA (50mg) |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
914.0 |
130.57 |
– |
– |
– |
– |
– |
– |
MMS (2mL) |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
800.0 |
23.76 |
– |
– |
2AA (2mg) |
– |
– |
2397.3 |
94.63 |
– |
– |
2205.3 |
20.87 |
– |
– |
274.7 |
20.10 |
– |
– |
152.0 |
15.72 |
– |
– |
– |
– |
2AA (50mg) |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
189.0 |
5.73 |
MR:Mutation Rate; NPD:4-Nitro-1,2-phenylenediamine;SAZ: Sodium azide;9AA:9-Aminoacridine;MMS:Methyl methanesulfonate;2AA: 2-aminoanthracene
Summary Table of the Results of the Confirmatory Mutation Test
Confirmatory Mutation Test (Pre-Incubation Test) |
||||||||||||||||||||
Concentrations (mg/plate) |
Salmonella typhimuriumtester strains |
Escherichiacoli |
||||||||||||||||||
TA 98 |
TA 100 |
TA 1535 |
TA 1537 |
WP2uvrA |
||||||||||||||||
-S9 |
+S9 |
-S9 |
+S9 |
-S9 |
+S9 |
-S9 |
+S9 |
-S9 |
+S9 |
|||||||||||
Mean values of revertants per plate Mutation rate (MR) |
Mean |
MR |
Mean |
MR |
Mean |
MR |
Mean |
MR |
Mean |
MR |
Mean |
MR |
Mean |
MR |
Mean |
MR |
Mean |
MR |
Mean |
MR |
Untreated Control |
15.0 |
0.88 |
22.7 |
1.08 |
113.3 |
1.04 |
113.3 |
0.95 |
13.0 |
1.05 |
14.0 |
1.00 |
8.7 |
1.30 |
8.7 |
1.18 |
30.7 |
0.91 |
34.0 |
0.86 |
DMSO Control |
16.0 |
1.00 |
19.0 |
1.00 |
– |
– |
113.3 |
1.00 |
– |
– |
11.7 |
1.00 |
6.3 |
1.00 |
8.0 |
1.00 |
– |
– |
31.0 |
1.00 |
Ultrapure Water Control |
17.0 |
1.00 |
21.0 |
1.00 |
109.3 |
1.00 |
119.3 |
1.00 |
12.3 |
1.00 |
14.0 |
1.00 |
6.7 |
1.00 |
7.3 |
1.00 |
33.7 |
1.00 |
39.3 |
1.00 |
5000 |
17.0 |
1.00 |
14.3 |
0.68 |
67.7 |
0.62 |
108.7 |
0.91 |
11.3 |
0.92 |
13.7 |
0.98 |
8.7 |
1.30 |
7.0 |
0.95 |
34.3 |
1.02 |
37.3 |
0.95 |
1600 |
16.0 |
0.94 |
19.3 |
0.92 |
69.0 |
0.63 |
107.0 |
0.90 |
11.3 |
0.92 |
14.0 |
1.00 |
6.3 |
0.95 |
5.7 |
0.77 |
30.0 |
0.89 |
41.7 |
1.06 |
500 |
15.3 |
0.90 |
21.3 |
1.02 |
84.7 |
0.77 |
110.3 |
0.92 |
14.3 |
1.16 |
10.7 |
0.76 |
6.0 |
0.90 |
8.3 |
1.14 |
31.3 |
0.93 |
43.0 |
1.09 |
160 |
15.7 |
0.92 |
18.7 |
0.89 |
78.0 |
0.71 |
121.0 |
1.01 |
16.3 |
1.32 |
13.0 |
0.93 |
6.0 |
0.90 |
5.7 |
0.77 |
39.3 |
1.17 |
46.0 |
1.17 |
50 |
20.0 |
1.18 |
21.0 |
1.00 |
95.0 |
0.87 |
122.0 |
1.02 |
13.0 |
1.05 |
14.3 |
1.02 |
13.0 |
1.95 |
7.3 |
1.00 |
34.3 |
1.02 |
39.7 |
1.01 |
16 |
16.3 |
0.96 |
25.3 |
1.21 |
90.3 |
0.83 |
100.0 |
0.84 |
11.3 |
0.92 |
11.7 |
0.83 |
5.7 |
0.85 |
13.7 |
1.86 |
32.3 |
0.96 |
35.0 |
0.89 |
NPD (4mg) |
256.0 |
16.00 |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
SAZ (2mg) |
– |
– |
– |
– |
1584.0 |
14.49 |
– |
– |
1176.0 |
95.35 |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
9AA (50mg) |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
679.3 |
107.26 |
– |
– |
– |
– |
– |
– |
MMS (2mL) |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
1226.7 |
36.44 |
– |
– |
2AA (2mg) |
– |
– |
992.0 |
52.21 |
– |
– |
1464.0 |
12.92 |
– |
– |
211.0 |
18.09 |
– |
– |
115.0 |
14.38 |
– |
– |
– |
– |
2AA (50mg) |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
150.7 |
4.86 |
MR:Mutation Rate; NPD:4-Nitro-1,2-phenylenediamine;SAZ: Sodium azide;9AA:9-Aminoacridine;MMS:Methyl methanesulfonate;2AA: 2-aminoanthracene
Historical Control Values for Revertants/Plate (for the Period of 2008-2016)
|
Bacterial strains |
||||||
Historical control data of untreated control |
-S9 |
|
TA98 |
TA100 |
TA1535 |
TA1537 |
E. coli |
Average |
21.0 |
105.0 |
10.5 |
8.1 |
25.4 |
||
SD |
3.7 |
25.7 |
1.4 |
2.3 |
5.2 |
||
Minimum |
9 |
66 |
3 |
2 |
11 |
||
Maximum |
39 |
155 |
23 |
19 |
45 |
||
+S9 |
|
TA98 |
TA100 |
TA1535 |
TA1537 |
E. coli |
|
Average |
27.5 |
117.1 |
11.8 |
9.0 |
33.9 |
||
SD |
4.3 |
18.1 |
1.4 |
1.9 |
5.2 |
||
Minimum |
12 |
75 |
4 |
2 |
17 |
||
Maximum |
46 |
166 |
23 |
20 |
56 |
||
|
Bacterial strains |
||||||
Historical control data of DMSO control |
-S9 |
|
TA98 |
TA100 |
TA1535 |
TA1537 |
E. coli |
Average |
20.4 |
100.1 |
10.3 |
7.9 |
24.7 |
||
SD |
3.6 |
24.8 |
1.3 |
2.4 |
4.6 |
||
Minimum |
10 |
64 |
3 |
2 |
11 |
||
Maximum |
38 |
147 |
23 |
20 |
45 |
||
+S9 |
|
TA98 |
TA100 |
TA1535 |
TA1537 |
E. coli |
|
Average |
26.5 |
113.8 |
11.8 |
8.8 |
33.7 |
||
SD |
4.1 |
18.3 |
1.5 |
1.9 |
5.0 |
||
Minimum |
15 |
71 |
3 |
3 |
16 |
||
Maximum |
47 |
162 |
25 |
20 |
57 |
||
|
Bacterial strains |
||||||
Historical control data of Water control |
-S9 |
|
TA98 |
TA100 |
TA1535 |
TA1537 |
E. coli |
Average |
21.9 |
104.7 |
10.5 |
7.6 |
26.1 |
||
SD |
3.7 |
25.9 |
1.5 |
2.2 |
5.5 |
||
Minimum |
12 |
68 |
3 |
2 |
12 |
||
Maximum |
35 |
154 |
24 |
16 |
48 |
||
+S9 |
|
TA98 |
TA100 |
TA1535 |
TA1537 |
E. coli |
|
Average |
27.4 |
117.3 |
11.4 |
8.7 |
34.9 |
||
SD |
4.0 |
18.5 |
1.3 |
2.2 |
4.9 |
||
Minimum |
15 |
83 |
4 |
3 |
18 |
||
Maximum |
43 |
167 |
22 |
16 |
57 |
||
|
Bacterial strains |
||||||
Historical control data of positive controls |
-S9 |
|
TA98 |
TA100 |
TA1535 |
TA1537 |
E. coli |
Average |
260.1 |
977.2 |
847.3 |
478.6 |
724.5 |
||
SD |
31.8 |
150.6 |
126.3 |
104.5 |
65.0 |
||
Minimum |
123 |
521 |
359 |
110 |
320 |
||
Maximum |
664 |
1970 |
1855 |
1601 |
1313 |
||
+S9 |
|
TA98 |
TA100 |
TA1535 |
TA1537 |
E. coli |
|
Average |
1222.7 |
1436.4 |
164.1 |
147.0 |
257.7 |
||
SD |
274.9 |
318.3 |
33.1 |
20.1 |
72.5 |
||
Minimum |
386 |
583 |
85 |
69 |
140 |
||
Maximum |
2676 |
2988 |
498 |
399 |
477 |
Abbreviations: TA98, TA100, TA1535, TA1537: Salmonella typhimuriumTA98, TA100, TA1535,
TA1537;E. coli:Escherichia coliWP2uvrA
SD: Standard deviation; DMSO: Dimethyl sulfoxide
Applicant's summary and conclusion
- Conclusions:
- The reported data of this mutagenicity assay show that under the experimental conditions applied, the test item did not induce gene mutations by base pair changes or frameshifts in the genome of the strains used.
In conclusion, the test item Benzene, 1,1’oxybis(methyl-, sulfonated, ammonium salt (ca 50 %) has no mutagenic activity on the applied bacterium tester strains under the test conditions used in this study. - Executive summary:
The test itemBenzene, 1,1’oxybis(methyl-, sulfonated, ammonium salt (ca 50 %)was tested with regard to a potential mutagenic activity using the Bacterial Reverse Mutation Assay.
The experiments were carried out using histidine-requiring auxotroph strains ofSalmonella typhimurium(Salmonella typhimuriumTA98, TA100, TA1535 and TA1537), and the tryptophan-requiring auxotroph strain ofEscherichia coli(Escherichia coliWP2uvrA) in the presence and absence of a post mitochondrial supernatant (S9) prepared from livers of Phenobarbital/b-naphthoflavone-induced rats.
The study included a Preliminary Solubility Test, a Preliminary Concentration Range Finding Test (Informatory Toxicity Test), an Initial Mutation Test (Plate Incorporation Test), and a Confirmatory Mutation Test (Pre-Incubation Test).
Based on the results of the Solubility and the Concentration Range Finding Tests the test item was dissolved in ultrapure water (ASTM Type I). The vehicle was compatible with the survival of the bacteria and the S9 activity and appropriate historical control database is available in the testing laboratory.
Based on the results of the preliminary Concentration Range Finding Test the following concentrations of the test item were prepared and investigated in the Initial and Confirmatory Mutation Tests:5000; 1600; 500; 160; 50 and 16 µg/plate.
The selection of the concentration range was based on the recommendations in OECD 471 guideline [6] for non-toxic, soluble test compounds; accordingly the test item was investigated up to and including the concentration level of 5000 µg/plate.
At the preparation of the test item stock solution a correction (multiplier) factor of 1.96 (1/0.511=1.96) based on the active component content (of 51.1 %) was taken into consideration.
No precipitation of the test item was observed on the plates in the examined bacterial strains at any examined concentration level (±S9 Mix) throughout the study.
The test item did not show inhibitory, cytotoxic effects in the performed experiments. The colony and background lawn development was not affected in any case; the obtained revertant colony number decreases (compared to the revertant colony numbers of the vehicle control) remained within the biological variability range of the applied test system.
The revertant colony numbers of vehicle control (ultrapure water (ASTM Type I)) plates with and without S9 Mix demonstratedthe characteristic mean number of spontaneous revertantsthat was in line with the corresponding historical control data ranges.
The reference mutagen treatments (positive controls) showed the expected, biological relevant increases (more than 3-fold increase)in induced revertant coloniesand nearly all the number of revertants fell in the corresponding historical control ranges, thereby meeting the criteria for the positive controlin all experimental phases, in all tester strains.
No biologically relevant increases were observed in revertant colony numbers of any of the five test strains following treatment withBenzene, 1,1’oxybis(methyl-, sulfonated, ammonium salt (ca 50 %)at any concentration level, either in the presence or absence of metabolic activation (S9 Mix) in the performed experiments.
The reported data of this mutagenicity assay show (see Appendix I to IV) that under the experimental conditions applied, the test itemdid not induce gene mutations by base pair changes or frameshifts in the genome of the strains used.
In conclusion, the test itemBenzene, 1,1’oxybis(methyl-, sulfonated, ammonium salt (ca 50 %)has no mutagenic activity on the applied bacterium tester strainsunder the test conditions used in this study.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)